山外山12月31日获融资买入620.50万元，融资余额9486.18万元

Group 1 - The core viewpoint of the news highlights the financial performance and market activity of Chongqing Shanwaishan Blood Purification Technology Co., Ltd., indicating a significant increase in revenue and net profit year-on-year [2] - As of December 31, Shanwaishan's stock price decreased by 0.80%, with a trading volume of 42.07 million yuan, and a net financing buy of -0.95 million yuan [1] - The company has a financing balance of 94.86 million yuan, which accounts for 1.98% of its market capitalization, indicating a high level of financing activity compared to the past year [1] Group 2 - For the period from January to September 2025, Shanwaishan achieved an operating income of 584 million yuan, representing a year-on-year growth of 39.79%, and a net profit attributable to shareholders of 104 million yuan, up 68.68% [2] - The company has distributed a total of 104 million yuan in dividends since its A-share listing [2] - As of October 31, the number of shareholders increased by 8.86% to 11,200, while the average circulating shares per person decreased by 8.14% to 20,949 shares [2]